Company / Free Cash Flow
Korro Bio, Inc. Free Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$78.0M
FY2025
5-year range
-$79.0M / $33.2M
FY2021-FY2025
Trend
-3.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 6 years, ranging from -$79M in FY2022 to $33M in FY2020.
Based on SEC 10-K filings.
-$78M in FY2025.
Remained stable around -$78M over the past 3 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow decreased 3.8% year-over-year.
- Peak free cash flow was recorded in FY2020.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$78.0M | -3.8% |
| FY2024 | -$75.1M | +4.9% |
| FY2022 | -$79.0M | -52.3% |
| FY2021 | -$51.9M | -256.4% |
| FY2020 | $33.2M | +301.2% |
| FY2019 | -$16.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026